Dr. Richard Lemons, a recognized expert on the topic of gene therapy, will review Hemgenix clinical data with updated results to provide a robust perspective of treatment effect and a fresh look at gene therapy. This will deepen understanding of Hemgenix through a live Q&A discussion, including a patient advocate with first-hand experience.